FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eric Vonderheid

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Neoplasm Staging

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Julie Michelle Wu; Christopher D Gocke; NANETTE LIEGEOIS; JEAN MORESI; Eric Vonderheid; Michael J Borowitz
Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas.
Marshall E Kadin; Igor Y Pavlov; Julio C Delgado; Eric Vonderheid
High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.
Alexandra C Hristov; Eric Vonderheid; Michael J Borowitz
Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eric Vonderheid (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Julie Michelle Wu; Christopher D Gocke; NANETTE LIEGEOIS; JEAN MORESI; Eric Vonderheid; Michael J Borowitz
Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas.
Journal of cutaneous pathology 2012;39(10):918-28.
2012: Marshall E Kadin; Igor Y Pavlov; Julio C Delgado; Eric Vonderheid
High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.
The Journal of investigative dermatology 2012;132(3 Pt 1):703-10.
2011: Alexandra C Hristov; Eric Vonderheid; Michael J Borowitz
Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
American journal of clinical pathology 2011;136(6):944-53.
2011: Eric Vonderheid; Marshall E Kadin; Christopher D Gocke
Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis?
The American Journal of dermatopathology 2011;33(8):835-40.
2011: Maryam Haque; KATSUYA HISAMICHI; J Steve Hou; Koji Tamada; Mark Abdelmalek; Robert E Brown; Carrie Ann Cusack; Eric Vonderheid
Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.
Clinical lymphoma, myeloma & leukemia 2011;11(6):453-61.
2011: Elise A Olsen; Pablo L Ortiz-Romero; Sareeta Parker; Nicola Pimpinelli; Lauren Pinter-Brown; Mark Pittelkow; H Miles Prince; Annamari Ranki; Steve Rosen; José Antonio Sanches; Makoto Sugaya; Maartan Vermeer; Eric Vonderheid; Sean Whittaker; Rein Willemze; Gary S Wood; Martine Bagot; Maria Grazia Bernengo; Günter Burg; Lorenzo Cerroni; Marie-France Demierre; Brigette Dreno; Reinhard Dummer; Madeleine Duvic; Teresa Estrach; Larisa Geskin; Michael Girardi; Joan Guitart; Peter Heald; Richard Hoppe; Steven Horwitz; Keiji Iwatsuki; Youn H Kim; Robert Knobler; Stuart R Lessin
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(18):2598-607.
2011: Jianqiang Wu; Jawed Siddiqui; Minakshi Nihal; Eric Vonderheid; Gary S Wood
Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).
Archives of biochemistry and biophysics 2011;508(2):185-91.
2011: Xingcao Nie; Eric Vonderheid; Essel Dulaimi Al-Saleem; Rekha Bhat; J Steve Hou
Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome.
Advances in hematology 2011;2011():875135.
2010: Alain H Rook; Gary S Wood; Madeleine Duvic; Eric Vonderheid; Alfonso Tobia; Bernard Cabana
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis.
Journal of the American Academy of Dermatology 2010;63(6):984-90.
2010: Marshall E Kadin; Eric Vonderheid
Targeted therapies: Denileukin diftitox--a step towards a 'magic bullet' for CTCL.
Nature reviews. Clinical oncology 2010;7(8):430-2.
2010: Laura McGirt; Christopher J Thoburn; Allan Hess; Eric Vonderheid
Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.
Photodermatology, photoimmunology & photomedicine 2010;26(4):182-91.
2009: Madeleine Duvic; Elise A Olsen; Debra L Breneman; Theresa R Pacheco; Sareeta Parker; Eric Vonderheid; Rachel Abuav; Justin L Ricker; Syed Rizvi; Cong Chen; Kathleen Boileau; Alexandra Gunchenko; Cesar Sanz-Rodriguez; Larisa J Geskin
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.
Clinical lymphoma & myeloma 2009;9(6):412-6.
2009: Anne-Chantal Knol; Benjamin D Ehst; A Dompmartin; Gaëlle Quéreux; J M Nguyen; F Comoz; J J Renaut; Amir Khammari; Eric Vonderheid; Brigitte Dréno
Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma.
The British journal of dermatology 2009;161(6):1414-6.
2009: E Bisaccia; Eric Vonderheid; L Geskin
Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
The British journal of dermatology 2009;161(1):167-9.
2009: Jianqiang Wu; Minakshi Nihal; Jawed Siddiqui; Eric Vonderheid; Gary S Wood
Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
The Journal of investigative dermatology 2009;129(5):1165-73.
2008: Monika Kasprzycka; Qian Zhang; Agnieszka Witkiewicz; Michal Marzec; Magdalena Potoczek; Xiaobin Liu; Hong Yi Wang; Michael Milone; Samik Basu; Joanne Mauger; John K Choi; JT Abrams; J Steven Hou; Alain H Rook; Eric Vonderheid; Anders Woetmann; Niels Odum; Mariusz A Wasik
Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(4):2506-12.
2008: Benjamin D Ehst; Brigette Dréno; Eric Vonderheid
Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.
European journal of dermatology : EJD 2008;18(4):467-8.
2008: Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Mariusz A Wasik; David W Bahler; Allan Hess
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.
Leukemia & lymphoma 2008;49(6):1190-201.
2008: David W Bahler; Leah Hartung; Sally Hill; Glen M Bowen; Eric Vonderheid
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
Cytometry. Part B, Clinical cytometry 2008;74(3):156-62.
2008: Rebecca A Kazin; Paul Bujanauskas; Eric Vonderheid
Durable complete remission of mycosis fungoides following erythroderma induced by denileukin diftitox.
Journal of the American Academy of Dermatology 2008;58(2 Suppl):S31-2.
2008: Syrus Karsai; J Steve Hou; Gladys H Telang; Gary R Kantor; Peter C Nowell; Eric Vonderheid
Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature.
Dermatology (Basel, Switzerland) 2008;216(1):68-75.
2007: Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Emilie C Bright; Allan Hess
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.
The Journal of investigative dermatology 2007;127(12):2882-92.
2007: Catherine H Lee; Adam J Mamelak; Eric Vonderheid
Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
International journal of dermatology 2007;46(11):1198-204.
2007: Chenwei Liu; Nancy Shea; Sally Rucker; Linda Harvey; Paul Russo; Richard Saul; Mary F Lopez; Alvydas Mikulskis; Scott Kuzdzal; Eva Golenko; David Fishman; Eric Vonderheid; Susan Booher; Edward W Cowen; Sam T Hwang; Gordon R Whiteley
Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.
Proteomics 2007;7(22):4045-52.
2007: Edward W Cowen; C-W Liu; S M Steinberg; Sewon Kang; Eric Vonderheid; H S Kwak; Susan Booher; Emanuel F Petricoin; Lance A Liotta; Gordon R Whiteley; Sam T Hwang
Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis.
The British journal of dermatology 2007;157(5):946-53.
2007: Elise Olsen; Eric Vonderheid; Nicola Pimpinelli; Rein Willemze; Youn Kim; Robert Knobler; Herschel Zackheim; Madeleine Duvic; Teresa Estrach; STANFORD LAMBERG; Gary Wood; Reinhard Dummer; Annamari Ranki; Gunter Burg; Peter Heald; Mark Pittelkow; Maria Grazia Bernengo; Wolfram Sterry; Liliane Laroche; Franz Trautinger; Sean Whittaker
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Blood 2007;110(6):1713-22.
2006: Eric Vonderheid; Jane Pena; Peter C Nowell
Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging.
Leukemia & lymphoma 2006;47(9):1841-56.
2006: Eric Vonderheid; Marshall E Kadin
Papular mycosis fungoides: a variant of mycosis fungoides or lymphomatoid papulosis?
Journal of the American Academy of Dermatology 2006;55(1):177-80.
2006: Xin Mao; Guy Orchard; Eric Vonderheid; Peter C Nowell; Martine Bagot; Armand Bensussan; Robin Russell-Jones; Bryan D Young; Sean J Whittaker
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.
The Journal of investigative dermatology 2006;126(6):1388-95.
2006: Michael Nebozhyn; Andrey Loboda; Laszlo Kari; Alain H Rook; Eric Vonderheid; Stuart R Lessin; Carole Berger; Richard Edelson; Calen Nichols; Malik Yousef; Lalitha Gudipati; Meiling Shang; Michael K Showe; Louise C Showe
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.
Blood 2006;107(8):3189-96.
2006: Denise A S Batista; Eric Vonderheid; Anita E Hawkins; Laura Morsberger; Patricia Long; KATHLEEN MURPHY; Constance A Griffin
Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities.
Genes, chromosomes & cancer 2006;45(4):383-91.
2006: T Nagasawa; Qian Zhang; Puthiyaveettil N Raghunath; H Y Wong; Mouna El-Salem; Arpad Szallasi; Michal Marzec; Phyllis A Gimotty; Alain H Rook; Eric Vonderheid; Niels Odum; Mariusz A Wasik
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Leukemia research 2006;30(3):303-12.
2006: Eric Vonderheid
On the diagnosis of erythrodermic cutaneous T-cell lymphoma.
Journal of cutaneous pathology 2006;33 Suppl 1():27-42.
2005: Nicola Pimpinelli; Elise A Olsen; Marco Santucci; Eric Vonderheid; Andreas C Haeffner; Seth Stevens; Guenter Burg; Lorenzo Cerroni; Brigitte Dreno; Earl J Glusac; Joan Guitart; Peter Heald; Werner Kempf; Robert Knobler; Stuart R Lessin; Christian Sander; Bruce S Smoller; Gladys Telang; Sean Whittaker; Keiji Iwatsuki; Erik Obitz; Masahiro Takigawa; Maria L Turner; Gary S Wood
Defining early mycosis fungoides.
Journal of the American Academy of Dermatology 2005;53(6):1053-63.
2005: Julie C Schultz; Suzanne Granados; Eric Vonderheid; Sam T Hwang
T-cell clonality of peripheral blood lymphocytes in patients with lymphomatoid papulosis.
Journal of the American Academy of Dermatology 2005;53(1):152-5.
2005: Eric Vonderheid; William Matsui
Do neoplastic stem cells underlie the pathogenesis of cutaneous lymphomas?
Archives of dermatology 2005;141(5):641-2; author reply 642-3.
2005: Eric Vonderheid; Robert D Bigler; J Steve Hou
On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma.
The British journal of dermatology 2005;152(4):825-6; author reply 827.
2005: Eric Vonderheid; Christine M Boselli; Michael Conroy; Laurie Casaus; Lisa Cheley Espinoza; Prakash Venkataramani; Robert D Bigler; J Steve Hou
Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
The Journal of investigative dermatology 2005;124(3):651-61.
2004: Xin Mao; Guy Orchard; Debra M Lillington; Fiona Child; Eric Vonderheid; Peter C Nowell; M Bagot; Armand Bensussan; Robin Russell-Jones; Bryan D Young; Sean J Whittaker
BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
The British journal of dermatology 2004;151(3):546-56.
2003: Eric Vonderheid; Maria Grazia Bernengo
The Sézary syndrome: hematologic criteria.
Hematology/oncology clinics of North America 2003;17(6):1367-89, viii.
2003: Olivier Dereure; Edi Levi; Eric Vonderheid; Marshall E Kadin
Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis.
Archives of dermatology 2003;139(12):1571-5.
2003: Mary E McComb; Gladys H Telang; Eric Vonderheid
Secondary syphilis presenting as pseudolymphoma of the skin.
Journal of the American Academy of Dermatology 2003;49(2 Suppl Case Reports):S174-6.
2003: Eric Vonderheid
Photopheresis: current and future perspectives.
Journal of cutaneous medicine and surgery 2003;7(4 Suppl):1-2.
2003: Laszlo Kari; Andrey Loboda; Michael Nebozhyn; Alain H Rook; Eric Vonderheid; Calen Nichols; Virok Dezso; Celia Chang; Wen-Hwai Horng; James Johnston; Maria Wysocka; Michael K Showe; Louise C Showe
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.
The Journal of experimental medicine 2003;197(11):1477-88.
2003: Simon S Yoo; Michael Viglione; JEAN MORESI; Eric Vonderheid
Unilesional mycosis fungoides mimicking Bowen's disease.
The Journal of dermatology 2003;30(5):417-9.
2003: Simon S Yoo; Mark Tran; Grant J Anhalt; Terry Barrett; Eric Vonderheid
Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris.
The Journal of dermatology 2003;30(5):405-10.
2003: Eric Vonderheid
Treatment planning in cutaneous T-cell lymphoma.
Dermatologic therapy 2003;16(4):276-82.
2002: Olivier Dereure; Edi Levi; Eric Vonderheid; Marshall E Kadin
Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.
The Journal of investigative dermatology 2002;118(6):949-56.
2002: Qian Zhang; Renold J Capocasale; Floyd E Fox; Vahe Bedian; Eric Vonderheid; Alain H Rook; Jonni S Moore; Peter C Nowell; Dale S Haines; Mariusz A Wasik
Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
Archivum immunologiae et therapiae experimentalis 2002;50(6):421-9.
2002: Eric Vonderheid
Treatment of cutaneous T cell lymphoma: 2001.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;160():309-20.
2002: Eric Vonderheid; Maria Grazia Bernengo; Günter Burg; Madeleine Duvic; Peter Heald; Liliane Laroche; Elise Olsen; Mark Pittelkow; Robin Russell-Jones; Masahiro Takigawa; Rein Willemze
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
Journal of the American Academy of Dermatology 2002;46(1):95-106.
2001: JT Abrams; Brian J Balin; Eric Vonderheid
Association between Sézary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma.
Annals of the New York Academy of Sciences 2001;941():69-85.
2001: Alain H Rook; Mohamed H Zaki; Maria Wysocka; Gary S Wood; Madeleine Duvic; Louise C Showe; Francine M Foss; Michael Shapiro; Timothy M Kuzel; Elise A Olsen; Eric Vonderheid; R Laliberte; Matthew L Sherman
The role for interleukin-12 therapy of cutaneous T cell lymphoma.
Annals of the New York Academy of Sciences 2001;941():177-84.
2001: Eric Vonderheid; Robert D Bigler; A Kotecha; C M Boselli; Stuart R Lessin; Maria Grazia Bernengo; M Polansky
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
The Journal of investigative dermatology 2001;117(3):654-62.
2001: Madeleine Duvic; Elise A Olsen; G A Omura; John C Maize; Eric Vonderheid; C A Elmets; Jerome L Shupack; Marie-France Demierre; Timothy M Kuzel; D Y Sanders
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.
Journal of the American Academy of Dermatology 2001;44(6):940-7.
2001: Elise Olsen; Madeleine Duvic; A Frankel; Y Kim; Ann Martin; Eric Vonderheid; B Jegasothy; G Wood; Michael S Gordon; Peter Heald; Allan R Oseroff; L Pinter-Brown; G Bowen; Timothy M Kuzel; David P Fivenson; Francine M Foss; M Glode; Arturo Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; Patricia A Bacha; J Nichols
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):376-88.
2001: Karen Rebecca Suchin; M Cassin; S L Gottleib; S Sood; Andrew J Cucchiara; Eric Vonderheid; Alain H Rook
Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
Journal of the American Academy of Dermatology 2001;44(1):28-32.
2000: Herschel S Zackheim; Eric Vonderheid; D L Ramsay; Philip E LeBoit; J Rothfleisch; Mohammed Kashani-Sabet
Relative frequency of various forms of primary cutaneous lymphomas.
Journal of the American Academy of Dermatology 2000;43(5 Pt 1):793-6.
2000: Qian Zhang; Puthiyaveettil N Raghunath; Eric Vonderheid; Niels Odum; Mariusz A Wasik
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
The American journal of pathology 2000;157(4):1137-46.
2000: P J Gregg; G R Kantor; Gladys H Telang; Stuart R Lessin; Peter C Nowell; Eric Vonderheid
Sarcoidal tissue reaction in Sézary syndrome.
Journal of the American Academy of Dermatology 2000;43(2 Pt 2):372-6.
2000: Lorenzo M Galindo; Fernando U Garcia; C A Hanau; Stuart R Lessin; N Jhala; Robert D Bigler; Eric Vonderheid
Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
American journal of clinical pathology 2000;113(6):865-71.
2000: H Wu; Gladys H Telang; Stuart R Lessin; Eric Vonderheid
Mycosis fungoides with CD30-positive cells in the epidermis.
The American Journal of dermatopathology 2000;22(3):212-6.
1999: JT Abrams; Eric Vonderheid; S Kolbe; Denah M Appelt; EJ Arking; Brian J Balin
Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
Clinical and diagnostic laboratory immunology 1999;6(6):895-905.
1999: AJ Marrogi; M A Khan; Eric Vonderheid; Gary S Wood; EI McBurney
p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases.
Journal of cutaneous pathology 1999;26(8):369-78.
1999: Seth R Stevens; G M Bowen; M Duvic; Lloyd E King; Robert Knobler; Henry W Lim; D Margolis; E J Parry; Alain H Rook; George P Stricklin; Karen Rebecca Suchin; M D Tharp; Eric Vonderheid; John A Zic
Effectiveness of photopheresis in Sézary syndrome.
Archives of dermatology 1999;135(8):995-7.
1999: Alain H Rook; Gary S Wood; Elisa K Yoo; Rosalie Elenitsas; DM Kao; Matthew L Sherman; W K Witmer; Kenneth Rockwell; Ryan Shane; Stuart R Lessin; Eric Vonderheid
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.
Blood 1999;94(3):902-8.
1999: R S Bader; Gladys H Telang; Eric Vonderheid
Multinucleate-cell angiohistiocytoma occurring in a patient with mycosis fungoides.
Cutis; cutaneous medicine for the practitioner 1999;63(3):145-8.
1998: B Micaily; Curtis T Miyamoto; G Kantor; Stuart R Lessin; A Rook; L Brady; R Goodman; Eric Vonderheid
Radiotherapy for unilesional mycosis fungoides.
International journal of radiation oncology, biology, physics 1998;42(2):361-4.
1998: Eric Vonderheid; S K Ekbote; K Kerrigan; J D Kalmanson; E J Van Scott; A H Rook; JT Abrams
The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
The Journal of investigative dermatology 1998;110(6):946-50.
1998: Eric Vonderheid; Q Zhang; Stuart R Lessin; M Polansky; JT Abrams; Robert D Bigler; Mariusz A Wasik
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Journal of the American Academy of Dermatology 1998;38(2 Pt 1):207-20.
1997: L S Romero; GR Kantor; M W Levin; Eric Vonderheid
Localized cutaneous amyloidosis associated with mycosis fungoides.
Journal of the American Academy of Dermatology 1997;37(1):124-7.
1996: R D Bigler; C M Boselli; B Foley; Eric Vonderheid
Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.
The American journal of pathology 1996;149(5):1477-83.
1996: Alain H Rook; M Kubin; Floyd E Fox; Zeling Niu; M Cassin; BR Vowels; S L Gottleib; Eric Vonderheid; Stuart R Lessin; Trinchieri Giorgio
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.
Annals of the New York Academy of Sciences 1996;795():310-8.
1996: Qian Zhang; I Nowak; Eric Vonderheid; Alain H Rook; Marshall E Kadin; Peter C Nowell; L M Shaw; Mariusz A Wasik
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(17):9148-53.
1996: Mariusz A Wasik; R Sackstein; D Novick; J R Butmarc; Qian Zhang; Eric Vonderheid; Marshall E Kadin
Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.
Human pathology 1996;27(7):738-44.
1996: A Chott; Eric Vonderheid; S Olbricht; N N Miao; S P Balk; Marshall E Kadin
The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis.
The Journal of investigative dermatology 1996;106(4):696-700.
1996: D I Marks; Eric Vonderheid; B W Kurz; R D Bigler; K Sinha; D A Morgan; A Sukman; P C Nowell; D S Haines
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome.
British journal of haematology 1996;92(4):890-9.
1996: Eric Vonderheid; A Sajjadian; M E Kadin
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Journal of the American Academy of Dermatology 1996;34(3):470-81.
1996: Mariusz A Wasik; Eric Vonderheid; R D Bigler; R Marti; Stuart R Lessin; M Polansky; Marshall E Kadin
Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
Archives of dermatology 1996;132(1):42-7.
1995: K S Resnik; G R Kantor; Stuart R Lessin; M E Kadin; L Chooback; H S Cooper; Eric Vonderheid
Mycosis fungoides palmaris et plantaris.
Archives of dermatology 1995;131(9):1052-6.
1995: Renold J Capocasale; R J Lamb; Eric Vonderheid; Floyd E Fox; Alain H Rook; Peter C Nowell; Jonni S Moore
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(12):5501-5.
1995: Madeleine Duvic; D Moore; A Menter; Eric Vonderheid
Cutaneous T-cell lymphoma in association with silicone breast implants.
Journal of the American Academy of Dermatology 1995;32(6):939-42.
1995: Alain H Rook; M Kubin; M Cassin; Eric Vonderheid; BR Vowels; Jonathan T Wolfe; Stanley Wolf; A Singh; G Trinchieri; Stuart R Lessin
IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1491-8.
1994: S K Ghosh; JT Abrams; H Terunuma; Eric Vonderheid; E DeFreitas
Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma.
Blood 1994;84(8):2663-71.
1994: Eric Vonderheid; R D Bigler; A S Greenberg; S J Neukum; B Micaily
Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response.
American journal of clinical oncology 1994;17(3):255-63.
1994: Eric Vonderheid; L W Diamond; W A van Vloten; E Scheffer; C J Meijer; A W Cashell; J M Hardman; S M Lai; J Hermans; M J Matthews
Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Cancer 1994;73(1):207-18.
1993: K S Resnik; Eric Vonderheid
Home UV phototherapy of early mycosis fungoides: long-term follow-up observations in thirty-one patients.
Journal of the American Academy of Dermatology 1993;29(1):73-7.
1993: D A Sirois; A S Miller; R D Harwick; Eric Vonderheid
Oral manifestations of cutaneous T-cell lymphoma. A report of eight cases.
Oral surgery, oral medicine, and oral pathology 1993;75(6):700-5.
1993: Marshall E Kadin; Eric Vonderheid; L M Weiss
Absence of Epstein-Barr viral RNA in lymphomatoid papulosis.
The Journal of pathology 1993;170(2):145-8.
1992: W T Hsu; M B Toporcer; G R Kantor; Eric Vonderheid; M E Kadin
Cutaneous T-cell lymphoma with porokeratosis-like lesions.
Journal of the American Academy of Dermatology 1992;27(2 Pt 2):327-30.
1992: BR Vowels; M Cassin; Eric Vonderheid; Alain H Rook
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.
The Journal of investigative dermatology 1992;99(1):90-4.
1992: L J Gordon; M Lee; J J Conley; J Bufill; Eric Vonderheid
Mycosis fungoides of the larynx.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1992;107(1):120-3.
1992: P I Axelrod; B Lorber; Eric Vonderheid
Infections complicating mycosis fungoides and Sézary syndrome.
JAMA : the journal of the American Medical Association 1992;267(10):1354-8.
1992: Eric Vonderheid; L W Diamond; S M Lai; F Au; Michael DellaVecchia
Lymph node histopathologic findings in cutaneous T-cell lymphoma. A prognostic classification system based on morphologic assessment.
American journal of clinical pathology 1992;97(1):121-9.
1991: B A Agnarsson; Eric Vonderheid; Marshall E Kadin
CD8+ cutaneous T-cell lymphoma.
The American Journal of dermatopathology 1991;13(6):628-9.
1991: B D Goldman; M Bari; G R Kantor; M E Kadin; B Micaily; Eric Vonderheid
Cutaneous multilobated T-cell lymphoma with aggressive course.
Journal of the American Academy of Dermatology 1991;25(2 Pt 2):345-9.
1991: B Micaily; O Campbell; C Moser; Eric Vonderheid; L W Brady
Total skin electron beam and total nodal irradiation of cutaneous T-cell lymphoma.
International journal of radiation oncology, biology, physics 1991;20(4):809-13.
1991: JT Abrams; Stuart R Lessin; S K Ghosh; Peter C Nowell; W Ju; Eric Vonderheid; Alain H Rook; E DeFreitas
Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(5):1455-62.
1991: R D Bigler; Pamela Crilley; B Micaily; L W Brady; D Topolsky; S Bulova; Eric Vonderheid; Irina Brodsky
Autologous bone marrow transplantation for advanced stage mycosis fungoides.
Bone marrow transplantation 1991;7(2):133-7.
1991: R L Lipshutz; G R Kantor; Eric Vonderheid
Multiple penile syringomas mimicking verrucae.
International journal of dermatology 1991;30(1):69.
1991: JT Abrams; Stuart R Lessin; S K Ghosh; W Ju; Eric Vonderheid; Peter C Nowell; G Murphy; B Elfenbein; E DeFreitas
A clonal CD4-positive T-cell line established from the blood of a patient with Sézary syndrome.
The Journal of investigative dermatology 1991;96(1):31-7.
1990: Eric Vonderheid; C A Kang; M Kadin; R D Bigler; T D Griffin; T J Rogers
Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations.
Journal of the American Academy of Dermatology 1990;23(4 Pt 1):703-12.
1990: B Micaily; C Moser; Eric Vonderheid; C Koprowski; D Lightfoot; Arnold Markoe; L Brady
The radiation therapy of early stage cutaneous T-cell lymphoma.
International journal of radiation oncology, biology, physics 1990;18(6):1333-9.
1990: B A Agnarsson; Eric Vonderheid; Marshall E Kadin
Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.
Journal of the American Academy of Dermatology 1990;22(4):569-77.
1990: F J Varga; Eric Vonderheid; S M Olbricht; Marshall E Kadin
Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta.
The American journal of pathology 1990;136(4):979-87.
1989: Eric Vonderheid; R D Bigler; T J Rogers; M E Kadin; T D Griffin
Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris.
The Yale journal of biology and medicine 1989;62(6):653-64.
1989: A F Kantor; Rochelle E Curtis; Eric Vonderheid; E J van Scott; Joseph Fraumeni
Risk of second malignancy after cutaneous T-cell lymphoma.
Cancer 1989;63(8):1612-5.
1989: Eric Vonderheid; E T Tan; A F Kantor; L Shrager; B Micaily; E J Van Scott
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
Journal of the American Academy of Dermatology 1989;20(3):416-28.
1988: G E Fronko; Robert J Suhadolnik; Eric Vonderheid; K Karikó; N L Reichenbach; Kenneth D Chavin; Earl E Henderson
Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b.
Biochemical and biophysical research communications 1988;153(1):448-53.
1988: Stuart R Lessin; G L Grove; L W Diamond; F C Au; Peter C Nowell; Eric Vonderheid
DNA-cytophotometry of lymph node touch imprints in cutaneous T-cell lymphoma.
The Journal of investigative dermatology 1988;90(4):425-9.
1987: Nancy B Spinner; Beverly S Emanuel; Eric Vonderheid; Peter C Nowell
Chronic myelomonocytic leukemia in a patient with a familial t(6;16)(q13;q22) translocation.
Cancer genetics and cytogenetics 1987;29(1):159-64.
1987: Leszek Kaczmarek; I B Elfenbein; F Narni; Eric Vonderheid; W E Barry; B Calabretta
The effect of cytosine-arabinoside treatment on the overexpression of c-myc protooncogene in a case of prolymphocytic leukemia.
Cancer genetics and cytogenetics 1987;27(1):89-99.
1987: Eric Vonderheid; E Tan; E L Sobel; E Schwab; B Micaily; B V Jegasothy
Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.
Journal of the American Academy of Dermatology 1987;17(1):40-52.
1987: Eric Vonderheid; R Thompson; K A Smiles; A Lattanand
Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Archives of dermatology 1987;123(6):757-63.
1987: R Edelson; C Berger; Francis P Gasparro; B Jegasothy; Peter Heald; B Wintroub; Eric Vonderheid; Robert Knobler; K Wolff; G Plewig
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.
The New England journal of medicine 1987;316(6):297-303.
1987: Marshall E Kadin; Eric Vonderheid; D Sako; Linda K Clayton; S Olbricht
Clonal composition of T cells in lymphomatoid papulosis.
The American journal of pathology 1987;126(1):13-7.
1987: Eric Vonderheid; E L Sobel; R D Hoeldtke; Gary J Faerber; V S Sardi
Kynurenic acid and xanthurenic acid excretion after tryptophan loading in actinic reticuloid.
International journal of dermatology 1987;26(1):33-41.
1986: Peter C Nowell; Eric Vonderheid; E Besa; J A Hoxie; L Moreau; J B Finan
The most common chromosome change in 86 chronic B cell or T cell tumors: a 14q32 translocation.
Cancer genetics and cytogenetics 1986;19(3-4):219-27.
1985: L M Stokar; Eric Vonderheid; E Abell; L W Diamond; S E Rosen; M I Goldwein
Clinical manifestations of intrathoracic cutaneous T-cell lymphoma.
Cancer 1985;56(11):2694-702.
1985: Eric Vonderheid; B Micaily
Treatment of cutaneous T-cell lymphoma.
Dermatologic clinics 1985;3(4):673-87.
1985: Eric Vonderheid; E L Sobel; P C Nowell; J B Finan; M K Helfrich; D S Whipple
Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma.
Blood 1985;66(2):358-66.
1985: B Micaily; Eric Vonderheid; L W Brady; C Andrews
Total skin electron beam and total nodal irradiation for treatment of patients with cutaneous T-cell lymphoma.
International journal of radiation oncology, biology, physics 1985;11(6):1111-5.
1985: K Nasu; J Said; Eric Vonderheid; J Olerud; D Sako; M Kadin
Immunopathology of cutaneous T-cell lymphomas.
The American journal of pathology 1985;119(3):436-47.
1985: M Kadin; K Nasu; D Sako; J Said; Eric Vonderheid
Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.
The American journal of pathology 1985;119(2):315-25.
1985: S F Berkowitz; B C Hirsh; Eric Vonderheid
Granular cell tumor: a great masquerader.
Cutis; cutaneous medicine for the practitioner 1985;35(4):355-6.
1984: A Chu; J Patterson; C Berger; Eric Vonderheid; R Edelson
In situ study of T-cell subpopulations in cutaneous T-cell lymphoma. Diagnostic criteria.
Cancer 1984;54(11):2414-22.
1984: Eric Vonderheid
Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
International journal of dermatology 1984;23(3):180-6.
1984: Eric Vonderheid; Robert J Suhadolnik; E L Sobel; M B Flick; Joseph Mosca
Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma.
Clinical immunology and immunopathology 1984;31(1):138-50.
1984: S E Rosen; Eric Vonderheid; I Koprowska
Mycosis fungoides with pulmonary involvement. Cytopathologic findings.
Acta cytologica 1984;28(1):51-7.
1983: Robert J Suhadolnik; M B Flick; Joseph Mosca; Y Sawada; Paul W. Doetsch; Eric Vonderheid
2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesis.
Biochemistry 1983;22(17):4153-8.
1983: B A Neilan; Eric Vonderheid; K J O'Neill
Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas.
The Journal of investigative dermatology 1983;81(2):176-8.
1983: Robert C Gallo; V S Kalyanaraman; M G Sarngadharan; A Sliski; Eric Vonderheid; M Maeda; Y Nakao; K Yamada; Y Ito; N Gutensohn; S Murphy; P A Bunn; D Catovsky; M F Greaves; Douglas W Blayney; William A Blattner; W F Jarrett; Harald zur Hausen; M Seligmann; J C Brouet; B F Haynes; B V Jegasothy; E Jaffe; J Cossman; S Broder; Richard I Fisher; D W Golde; M Robert-Guroff
Association of the human type C retrovirus with a subset of adult T-cell cancers.
Cancer research 1983;43(8):3892-9.
1983: B Micaily; Eric Vonderheid; L W Brady
Combined moderate dose electron beam radiotherapy and topical chemotherapy for cutaneous T-Cell lymphoma.
International journal of radiation oncology, biology, physics 1983;9(4):475-9.
1983: Eric Vonderheid; E J Van Scott
Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
Cleveland Clinic quarterly 1983;50(2):97-100.
1982: S E Rosen; I Koprowska; Eric Vonderheid
Skin imprint cytology in the diagnosis of cutaneous T-cell lymphomas. A preliminary report.
Acta cytologica 1982;26(6):819-22.
1982: H J Milstein; Eric Vonderheid; E J Van Scott; W C Johnson
Home ultraviolet phototherapy of early mycosis fungoides: preliminary observations.
Journal of the American Academy of Dermatology 1982;6(3):355-62.
1982: M H Greene; H A Pinto; J A Kant; K Siler; Eric Vonderheid; STANFORD LAMBERG; N A Dalager
Lymphomas and leukemias in the relatives of patients with mycosis fungoides.
Cancer 1982;49(4):737-41.
1982: P C Nowell; J B Finan; Eric Vonderheid
Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin.
The Journal of investigative dermatology 1982;78(1):69-75.
1981: Eric Vonderheid; D L Dellatorre; E J Van Scott
Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
Archives of dermatology 1981;117(9):586-9.
1981: Eric Vonderheid; S M Fang; M K Helfrich; S R Abraham; C A Nicolini
Biophysical characterization of normal T-lymphocytes and Sézary cells.
The Journal of investigative dermatology 1981;76(1):28-37.
1981: Eric Vonderheid; D W Tam; W C Johnson; E J Van Scott; P E Wallner
Prognostic significance of cytomorphology in the cutaneous T-cell lymphomas.
Cancer 1981;47(1):119-25.
1980: S Abraham; Eric Vonderheid; S Zietz; F M Kendall; C Nicolini
Reversible (G0) and nonreadily reversible (Q) noncycling cells in human peripheral blood. Immunological, structural, and biological characterization.
Cell biophysics 1980;2(4):353-71.
1980: Eric Vonderheid; H J Milstein; K D Thompson; B C Wu
Chronic herpes simplex infection in cutaneous T-cell lymphomas.
Archives of dermatology 1980;116(9):1018-22.
1980: Eric Vonderheid
Evaluation and treatment of mycosis fungoides lymphoma.
International journal of dermatology 1980;19(4):182-8.
1980: Eric Vonderheid; P C van Voorst Vader
Herpes zoster-varicella in cutaneous T-cell lymphomas.
Archives of dermatology 1980;116(4):408-12.
1979: R A Harper; D W Tam; Eric Vonderheid; F Urbach
Normal T-lymphocyte function in psoriatic patients undergoing methoxsalen photochemotherapy.
The Journal of investigative dermatology 1979;72(6):323-5.
1979: STANFORD LAMBERG; S B Green; D P Byar; J B Block; W E Clendenning; E H Epstein; Z Y Fuks; L E Golitz; A L Lorincz; B Michel; H H Roenigk; E J Van Scott; Eric Vonderheid; R J Thomas
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
Cancer treatment reports 1979;63(4):701-7.
1979: Eric Vonderheid; E J Van Scott; P E Wallner; W C Johnson
A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
Cancer treatment reports 1979;63(4):681-9.
1979: P E Wallner; Eric Vonderheid; L W Brady; E J Van Scott; S O Asbell
Evaluation and recommendations for therapy of advanced mycosis fungoides lymphoma.
International journal of radiation oncology, biology, physics 1979;5(1):23-7.
1978: A Du Vivier; Eric Vonderheid; E J Van Scott; F Urbach
Mycosis fungoides, nitrogen mustard and skin cancer.
The British journal of dermatology 1978;99(1):61-3.
1978: A du Vivier; R A Harper; Eric Vonderheid; E J Van Scott
Lymphocyte transformation in patients with staged mycosis fungoides and Sézary syndrome.
Cancer 1978;42(1):209-13.
1978: S O Asbell; N Gadol; P Saluk; Eric Vonderheid; L W Brady
Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome.
International journal of radiation oncology, biology, physics 1978;4(7-8):609-13.
1977: B Lorber; Eric Vonderheid; R M Swenson; K R Cundy
Failure of isoniazid to cure localized BCG infection.
JAMA : the journal of the American Medical Association 1977;238(1):55.
1977: Eric Vonderheid; E J Van Scott; W C Johnson; David Grekin; S O Asbell
Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Archives of dermatology 1977;113(4):454-62.
1976: Eric Vonderheid; P J Koblenzer; P M Ming; C F Burgoon
Neonatal lupus erythematosus. Report of four cases with review of the literature.
Archives of dermatology 1976;112(5):698-705.
1975: E J Van Scott; David Grekin; J D Kalmanson; Eric Vonderheid; W E Barry
Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
Cancer 1975;36(5):1613-8.